HDV - iShares Core High Dividend ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
91.04
+1.08 (+1.20%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close89.96
Open90.68
Bid0.00 x 1400
Ask0.00 x 1200
Day's Range90.61 - 91.04
52 Week Range79.39 - 93.12
Volume350,256
Avg. Volume1,031,790
Net Assets6.6B
NAV89.98
PE Ratio (TTM)N/A
Yield3.50%
YTD Return6.70%
Beta (3Y Monthly)0.72
Expense Ratio (net)0.08%
Inception Date2011-03-29
Trade prices are not sourced from all markets
  • Emerging Market and Dividend: 2 ETFs to Watch on Outsized Volume
    Zacks23 days ago

    Emerging Market and Dividend: 2 ETFs to Watch on Outsized Volume

    PIE and HDV saw massive trading volumes in yesterday session.

  • Zackslast month

    Banks Keep Stocks Moving Higher

    Banks Keep Stocks Moving Higher

  • A Dividend ETF Investing Guide
    Zacks2 months ago

    A Dividend ETF Investing Guide

    Dividend paying securities are the major source of consistent income for investors to create wealth when returns from the equity market are at risk.

  • Merck’s Stock Price Has Increased ~34% in 2018
    Market Realist3 months ago

    Merck’s Stock Price Has Increased ~34% in 2018

    On November 16, Merck’s (MRK) stock price closed at $76.06, which represents ~1.63% growth from its close of $74.84 on November 15. Merck’s stock price grew from $56.79 when the market opened on January 2 to $76.06 when the market closed on November 16, which representing ~34% year-to-date growth. On November 16, Merck hit its 52-week high of $76.25.

  • Top ETFs: As Dividends Compare More Favorably, IShares ETF Emerges As A Leader
    Investor's Business Daily3 months ago

    Top ETFs: As Dividends Compare More Favorably, IShares ETF Emerges As A Leader

    When the stock market gets rough, investors often flee to dividend stocks, which explains why iShares Core High Dividend is now in IBD's ETF Leaders screen of top ETFs.

  • How Wall Street Analysts View Merck
    Market Realist4 months ago

    How Wall Street Analysts View Merck

    On October 25, Merck & Co. (MRK) announced a dividend of $0.55 per share for its outstanding common stock in the fourth quarter of 2018. That’s a ~15% increase from its dividend of $0.48 per share in the fourth quarter of 2017.

  • 37% of Analysts Rate 3M as a ‘Buy’ after Its Q3 2018 Earnings
    Market Realist4 months ago

    37% of Analysts Rate 3M as a ‘Buy’ after Its Q3 2018 Earnings

    The consensus target price for 3M stock has fallen since its earnings release. The current analyst consensus indicates a target price of $205.94, compared to $213.60 before its third-quarter earnings release.

  • How Is Johnson & Johnson’s Vision Care Business Positioned?
    Market Realist4 months ago

    How Is Johnson & Johnson’s Vision Care Business Positioned?

    Johnson & Johnson’s (JNJ) Vision Care segment generated revenues of $1.13 billion in the third quarter compared to $1.09 billion in the third quarter of 2017, reflecting ~3.8% YoY (year-over-year) growth.

  • What’s Pfizer’s Current Valuation?
    Market Realist4 months ago

    What’s Pfizer’s Current Valuation?

    In this part, we’ll compare Pfizer’s (PFE) valuation with its peers including Merck (MRK), Johnson & Johnson (JNJ), Eli Lilly (LLY), and Bristol-Myers Squibb (BMY).

  • A Guide to Dividend ETF Investing
    Zacks4 months ago

    A Guide to Dividend ETF Investing

    We have highlighted 10 most popular dividend ETFs for investors seeking yields and returns in a rocky market.

  • What’s Expected for Merck’s Q3 2018 Earnings
    Market Realist4 months ago

    What’s Expected for Merck’s Q3 2018 Earnings

    Analysts expect Merck (MRK) to report GAAP net income of $2.23 billion and GAAP EPS of $0.83 in the third quarter of 2018. In Q2 2018, the company’s GAAP net income fell YoY (year-over-year) from $1.9 billion to $1.7 billion, and its GAAP EPS fell YoY from $0.71 to $0.63. Merck’s non-GAAP net income grew ~3% YoY in Q2 2018, to $2.9 billion from $2.8 billion, and its non-GAAP EPS grew ~5% YoY from $1.01 to $1.06.

  • Pfizer’s Dividend Growth Trend and Analysts’ Recommendations
    Market Realist5 months ago

    Pfizer’s Dividend Growth Trend and Analysts’ Recommendations

    In June, Pfizer (PFE) announced a dividend of $0.34 for the third quarter on the company’s common stock. Pfizer paid a cash dividend of $0.34 on September 4 to its shareholders of record on August 3. Pfizer delivered a dividend yield of 3.11% in the third quarter.

  • 7 Inexpensive High Dividend ETFs to Buy
    InvestorPlace5 months ago

    7 Inexpensive High Dividend ETFs to Buy

    The universe of exchange-traded funds (ETFs) is awash in low-fee products and that space is growing as issuers use discounted fees to lure investors.

  • ETF Trends7 months ago

    Dividend ETFs: Capitalizing on a Trump Bump?

    President Donald Trump enacted a tax reform plan that allowed companies to repatriate billions of dollars in overseas revenue back home, driving increased demand for dividend stock ETF strategies that ...

  • Merck’s Post-1Q18 Valuation
    Market Realist9 months ago

    Merck’s Post-1Q18 Valuation

    In 1Q18, Merck’s revenue grew 6% YoY (year-over-year) to $10.0 billion from $9.4 billion, and its EPS (earning per share) rose to $1.05 from $0.88. In this part, we’ll look at how Merck’s valuation multiples compare.

  • What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?
    Market Realist10 months ago

    What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?

    As discussed earlier, Johnson & Johnson (JNJ) reported revenue growth of 12.6% in its 1Q18 revenues to $20.0 billion.

  • Analysts’ Recommendations for Johnson & Johnson on April 16
    Market Realist10 months ago

    Analysts’ Recommendations for Johnson & Johnson on April 16

    Johnson & Johnson (JNJ) reported revenues of $20.2 billion during 4Q17—11.5% growth compared to 4Q16. Wall Street analysts expect Johnson & Johnson to generate earnings per share of $2.00 on revenues of $19.4 billion in 1Q18—9.2% revenue growth compared to $17.8 billion in 1Q17. The revenue growth is expected to be driven by increased sales across all three business segments.

  • InvestorPlace10 months ago

    3 Top Low-Cost Dividend Funds to Buy

    When it comes to investing in dividend funds, there are a few trade-offs to be aware of. Of course, everyone is looking for low-cost dividend funds, and yet low-cost dividend funds usually mean passively managed exchange-traded funds or mutual funds. Expenses are going to rise as you move into higher-yielding securities that require more active management.

  • Factors that Could Drive Dominion Energy’s Dividend Growth
    Market Realistlast year

    Factors that Could Drive Dominion Energy’s Dividend Growth

    What Are the Top S&P 500 Utility Dividend Growers?